Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03414034
What this trial is testing

Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Cardiff Oncology 72
Testing effectiveness (Phase 2)Study completedNCT03570619
What this trial is testing

Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

Who this might be right for
Metastatic Castration Resistant Prostate CancerMetastatic CancerSolid Tumor
University of Michigan Rogel Cancer Center 56
Large-scale testing (Phase 3)Study completedNCT00191607
What this trial is testing

Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.

Who this might be right for
Genital Neoplasms, FemaleFallopian Tube NeoplasmsOvarian Neoplasms+2 more
Eli Lilly and Company 162
Early research (Phase 1)Not Yet RecruitingNCT07461727
What this trial is testing

An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases

Who this might be right for
Non-Small Cell Lung CancerMetastatic Non-small Cell Lung CancerLiver Metastases+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 15
Early research (Phase 1)Study completedNCT04521361
What this trial is testing

Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones

Who this might be right for
Bone Metastatic Castration-resistant Prostate Cancer
Bayer 46
Testing effectiveness (Phase 2)Study completedNCT01487720
What this trial is testing

GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Asan Medical Center 33
Early research (Phase 1)Temporarily pausedNCT05629546
What this trial is testing

Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

Who this might be right for
Advanced MelanomaMetastatic Melanoma
Washington University School of Medicine 33
Testing effectiveness (Phase 2)Study completedNCT01254513
What this trial is testing

Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients

Who this might be right for
Prostate Cancer
UNICANCER 66
Large-scale testing (Phase 3)Study completedNCT02887976
What this trial is testing

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

Who this might be right for
Prostate Cancer
GU Research Network, LLC 2
Testing effectiveness (Phase 2)WithdrawnNCT04626089
What this trial is testing

Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Metabolic SyndromeType 2 Diabetes
Laboratorios Silanes S.A. de C.V.
Testing effectiveness (Phase 2)Active Not RecruitingNCT03012321
What this trial is testing

Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Who this might be right for
Prostate Cancer Metastatic Castration-ResistantAbnormal DNA RepairMetastatic Prostate Carcinoma+1 more
Northwestern University 70
Testing effectiveness (Phase 2)Looking for participantsNCT07441889
What this trial is testing

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

Who this might be right for
Breast CancerProstate Cancer
University of Virginia 23
Early research (Phase 1)Looking for participantsNCT04729114
What this trial is testing

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration Resistant Prostate CancerMetastatic Castration-sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 174
Early research (Phase 1)Study completedNCT04397276
What this trial is testing

JNJ-70218902 in Participants With Advanced Stage Solid Tumors

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 82
Testing effectiveness (Phase 2)Study completedNCT00210652
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 47
Testing effectiveness (Phase 2)Ended earlyNCT03572478
What this trial is testing

Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer

Who this might be right for
Prostate CancerEndometrial Cancer
University of Chicago 12
Large-scale testing (Phase 3)Study completedNCT00887198
What this trial is testing

Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 1,088
Testing effectiveness (Phase 2)Study completedNCT02962284
What this trial is testing

One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™

Who this might be right for
Metastatic Prostate Cancer
Sun Pharmaceutical Industries Limited 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06909825
What this trial is testing

FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Fusion Pharmaceuticals Inc. 85
Not applicableStudy completedNCT02702908
What this trial is testing

Second Primary Cancers in Patients With Castration Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Bayer 6,442
Next Page